Actavis Laboratories, FL, Inc. voluntarily recalled Diclofenac Sodium and Misoprostol Delayed-Release Tablets due to failed tablet specifications, the FDA said on April 24, 2014. The recall involves 36,538 bottles distributed nationwide and in Puerto Rico.
How to tell if you have it
- Brand: Actavis
- Product: Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle
- NDC: 0591-0398-60
- UPC: 3 05910 39860 6
- Lot codes: 605956A (Exp. 9/30/2014), 605958A (Exp. 10/31/2014), 661841A (Exp. 11/30/2014), 717469A (Exp. 2/28/2015)
- Manufacturer: Watson Laboratories, Inc., Corona, CA
The hazard
The FDA said the recall is due to complaints of split or broken tablets resulting from failed tablet specifications.
Context
GovInfoNow's records show Actavis Laboratories, FL, Inc. has five other recalls on record since Sept. 26, 2014. Other recent recalls of similar products include Actavis Ramipril Recall (Aug. 30, 2016), Actavis Metformin ER Recall (Sept. 25, 2015), and Actavis Recalls Desmopressin Tablets Due to Wrong ID Imprint (June 23, 2015). Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), Teva Metoprolol Succinate Extended-Release Tablets Recall (Jan. 29, 2026), and Teva Recalls Metoprolol Succinate 50 mg Due to Dissolution Failure (Jan. 29, 2026).